Role of early vascular damage in the pathogenesis of gastric haemorrhagic mucosal lesions induced by indomethacin in rats. 1996

E Gyömber, and P Vattay, and S Szabo, and K D Rainsford
Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.

Early vascular injury is a key element in the pathogenesis of gastric haemorrhagic mucosal lesions which develop rapidly after intragastric (i.g.) administration of ethanol, HCl or NaOH. The sequence of vascular events leading to gastric lesions has not, however, been investigated in detail with ulcerogenic non-steroidal anti-inflammatory drugs such as indomethacin (IND). Accordingly, experiments were performed in rats using the vascular tracer Monastral blue to assess whether vascular lesions precede and are subsequently associated with mucosal lesions induced by oral (p.o.) or subcutaneous (s.c.) administration of IND. Fasted female Sprague-Dawley rats (150-180 g) were given IND either at 100 mg/kg, p.o. or 200 mg/kg s.c. and killed 15, 30, 120 or 240 minutes later. Monastral blue, 3% saline 1 ml/kg, was injected intravenously under ether anaesthesia 3 minutes before autopsy and the formalin fixed, glycerol cleared stomachs were examined microscopically for deposition of the dye particles on damaged blood vessels. The percentage area of Monastral blue labelled vessels (measured by stereomicroscopic planimetry) at 15 minutes after oral IND was 10.1 +/- 1.5% (mean +/- s.e.m.) of glandular stomach and increased progressively to 64.5 +/- 3.0% at 240 minutes. Gastric haemorrhagic lesions (also measured by stereomicroscopic planimetry) were first evident at 30 minutes (0.2 +/- 0.03%; mean +/- s.e.m.), and developed progressively to 2.0 +/- 0.3% total area of glandular mucosa at 240 minutes. Subcutaneous injection of IND resulted in a delayed time of onset for the appearance and the extent of mucosal lesions (first appearing at 120 minutes, 0.1 +/- 0.03% area) compared with that from oral administration of the drug, but as with oral IND the vascular damage (first appearance at 15 minutes, 7.5 +/- 3.6%) clearly preceded the occurrence of gastric lesions. The observations of microvascular dye labelling were paralleled by observations of the electron-microscopic appearance of endothelial cell disruption in the region adjacent to superficial mucous cells and accumulation of red blood cells in the interstitium at 20-60 minutes. We conclude that vascular injury precedes haemorrhagic mucosal damage in the pathogenesis of IND-induced acute gastric mucosal lesions.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D001808 Blood Vessels Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins). Blood Vessel,Vessel, Blood,Vessels, Blood
D005260 Female Females
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D006471 Gastrointestinal Hemorrhage Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Hematochezia,Hemorrhage, Gastrointestinal,Gastrointestinal Hemorrhages,Hematochezias
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D013270 Stomach An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM. Stomachs

Related Publications

E Gyömber, and P Vattay, and S Szabo, and K D Rainsford
December 1998, Methods and findings in experimental and clinical pharmacology,
E Gyömber, and P Vattay, and S Szabo, and K D Rainsford
April 1995, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
E Gyömber, and P Vattay, and S Szabo, and K D Rainsford
January 2000, Journal of gastroenterology,
E Gyömber, and P Vattay, and S Szabo, and K D Rainsford
February 1988, Digestive diseases and sciences,
E Gyömber, and P Vattay, and S Szabo, and K D Rainsford
January 2000, Medical science monitor : international medical journal of experimental and clinical research,
E Gyömber, and P Vattay, and S Szabo, and K D Rainsford
January 2013, European review for medical and pharmacological sciences,
E Gyömber, and P Vattay, and S Szabo, and K D Rainsford
January 1993, Journal of clinical gastroenterology,
E Gyömber, and P Vattay, and S Szabo, and K D Rainsford
October 1986, Digestive diseases and sciences,
E Gyömber, and P Vattay, and S Szabo, and K D Rainsford
January 1998, Digestion,
Copied contents to your clipboard!